Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Daniel Murkes"'
Autor:
Parameswaran Grace Luther Lalitkumar, Eva Lundström, Birgitta Byström, Dorina Ujvari, Daniel Murkes, Edneia Tani, Gunnar Söderqvist
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 4, p 4123 (2023)
Recent studies suggest estradiol (E2)/natural progesterone (P) confers less breast cancer risk compared with conjugated equine estrogens (CEE)/synthetic progestogens. We investigate if differences in the regulation of breast cancer-related gene expre
Externí odkaz:
https://doaj.org/article/08db063ba2894c6e886e0b45ce9d6cbf
Publikováno v:
Gynecological Endocrinology. 28:12-15
Gene expression analysis of healthy postmenopausal women in a prospective clinical study indicated that genes encoding for epithelial proliferation markers Ki-67 and progesterone receptor B mRNA are differentially expressed in women using hormone the
Autor:
Daniel Murkes, Li Felländer-Tsai, Bo Westman, Ann Kjellin, Lars Enochsson, Liv Ahlborg, Leif Hedman
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology. 157:73-77
To analyze the relationship between visuospatial ability and simulated laparoscopy performed by consultants in obstetrics and gynecology (OBGYN).This was a prospective cohort study carried out at two community hospitals in Sweden. Thirteen consultant
Publikováno v:
Journal of Assisted Reproduction and Genetics. 15:70-75
Purpose: The ability of six morphological criteria (embryo development rate, fragmentation, regularity of blastomere shape, equality of blastomere size, zona pellucida thickness variation [ZPTV], and visible mononucleated blastomeres [VMBs]) to predi
Autor:
Edneia Tani, Peter Conner, Eva Lundström, Gunnar Söderqvist, Daniel Murkes, Karin Leifland, Aude Beliard
Publikováno v:
Fertility and sterility. 95(3)
In a prospective, randomized clinical study 77 women were assigned randomly to receive sequential hormone therapy with either conventional oral conjugated equine estrogens (0.625 mg) with the addition on 14 of the 28 days of oral medroxyprogesterone